OPINION: How Canada’s harm reduction became an asset for organized crime
· Toronto Sun

See more Toronto Sun on Google — save as a Preferred Source
The human toll of Canada’s drug crisis is measured in the progressive decay of chronic addiction that strips users of functionality, dignity, and sanity long before claiming their lives. Behind sterile public health debates, families endure a gauntlet of terror and grief. Against this backdrop of social collapse, Canada’s approach to harm reduction faces its most critical reckoning yet.
Visit moryak.biz for more information.
What began as an effort to reduce deaths through government-funded “safer supply” initiatives has unlocked a devastating secondary disaster. Under the existing model, patients received multi-day supplies, known as “carries,” so they could avoid daily clinic or pharmacy visits. Dealers ruthlessly exploited this loophole, pressuring or paying vulnerable users for take-home prescriptions, funneling free opioids onto the black market and expanding youth experimentation.
Even more concerning is how corporate physician groups have industrialized this pipeline. Operating under the banner of pain management and addiction care, multi-location chains across Ontario, some with dozens of storefronts, have become high-volume safe supply conduits. Relying on brief virtual appointments and routine urine screening with minimal oversight, these networks have arguably created a larger diversion problem than standalone clinics. On one side are cartels, and on the other are pill mills — leaving our healthcare system to cope with the fallout.
Community fear
The consequences on our streets are stark and destabilizing. Where drug networks have taken over public spaces, residents and merchants pay a crushing price. Illicit drug activity has driven theft, property damage, social disorder, and erratic street violence, including gang turf warfare and unprovoked attacks on innocent bystanders by individuals with co-occurring mental health and substance use disorders. Far from solving the crisis, the system has turned public spaces into zones of community fear.
Simultaneously, it inflicts a cruel irony on chronic pain patients; while family doctors fear regulatory backlash for prescribing legitimate pain relief, subsidized safe supply narcotics are traded on the sidewalk for pocket change. Meanwhile, small businesses face catastrophic losses and closures as customers flee out of fear.
At the centre of this crisis are Organized Crime Groups (OCGs), the architects of a lucrative, two-tiered illegal market. While local dealers and addicts trade government-funded hydromorphone on the street for pocket change, OCGs act as the true “big fish” controlling the wholesale supply of cheap, ultra-potent illicit fentanyl. Street users flip their pharma-grade pills for cash to buy fentanyl, allowing criminal networks to harvest diverted hydromorphone and traffic it into rural, suburban, and remote communities at a massive premium.
This arbitrage is seeding a predatory second wave of addiction in new demographics. By marketing diverted safe-supply pills as a “clean, pharma-grade” high, OCGs exploit public trust in prescription medicine to trap teenagers and young adults into rapid dependency. Because these tablets look legitimate, first-time users let their guard down, unaware that these subsidized pharmaceuticals act as a gateway to hard-wired addiction, and that organized crime eventually floods the market with counterfeit knock-offs laced with lethal fentanyl, risking fatal overdoses.
This compounding failure stems from a fundamental policy error. Dr. Gregory Shea, an expert in organizational change at the Wharton School of Management, writes that successful frameworks designed to produce a desired outcome must be carefully monitored. Canada missed this recipe, cherry-picking free narcotics while failing to build mandatory treatment pathways required for rehabilitation. Governments simply poured funds into distributing free substances, ignoring the warning from Dr. João Goulão, the chief architect of Portugal’s policy: “Decriminalization is not a silver bullet … If you decriminalize and do nothing else, things will get worse.”
A long-overdue regulatory correction is finally beginning. Driven by concerned citizens, municipal stakeholders, and the Ontario government under Premier Doug Ford, the College of Physicians and Surgeons of Ontario (CPSO) and the Ontario College of Pharmacists (OCP) have implemented strict rules taking effect Nov. 16 — mandating “no carries,” mandatory opioid agonist therapy like methadone or Suboxone, and mandatory monthly in-person doctor visits. This is a good start.
True systemic change requires moving past social media activism and applying sustained pressure on decision-makers. We must insist that MPs and MPPs fund treatment beds, and work with neighbourhood doctors and pharmacists to ensure these protective protocols are supported.
– James Boyd is a retired paramedic and youth advocate. His work blends lived experience and hard‑earned insight from a lifetime spent protecting others.